celecoxib has been researched along with ursodeoxycholic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dees, J; Dekker, E; Kampman, E; Koornstra, JJ; Langers, AM; Mathus-Vliegen, EM; Nagengast, FM; Nagtegaal, ID; Peters, WH; Roelofs, HM; van Heumen, BW; Vink-Börger, ME | 1 |
| Nagengast, FM; Peters, WH; Roelofs, HM; te Morsche, RH; van Heumen, BW | 1 |
| Khayyat, YM | 1 |
1 review(s) available for celecoxib and ursodeoxycholic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for celecoxib and ursodeoxycholic acid
| Article | Year |
|---|---|
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.
Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Celecoxib; Cholagogues and Choleretics; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Duodenum; Female; Humans; Intestinal Polyps; Male; Middle Aged; Pyrazoles; Sulfonamides; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2013 |
4 other study(ies) available for celecoxib and ursodeoxycholic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
Topics: Adenomatous Polyposis Coli; Adult; Aged; Cadherins; Caspase 3; Celecoxib; Cyclooxygenase 2; Duodenal Neoplasms; Female; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Hyaluronoglucosaminidase; Intestinal Mucosa; Male; Middle Aged; Proteins; Pyrazoles; Sulfonamides; Ursodeoxycholic Acid; Young Adult | 2013 |
Potential therapeutic benefit of ursodeoxycholic acid in the management of non hepato-biliary upper gastrointestinal disorders.
Topics: Adenomatous Polyposis Coli; Adult; Celecoxib; Drug Therapy, Combination; Dyspepsia; Humans; Ursodeoxycholic Acid | 2023 |